TCTR20210529001尚未招募4 期
Efficacy and applicability of topical cannabidiol-based treatment in psoriasis patient, randomized, placebo, controlled trial
Dermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital0 个研究点目标入组 30 人开始时间: 2021年5月29日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 70 Years(—)
- 性别
- All
入选标准
- •1. male/female 18-70 years 2. plaque type psoriasis, mild severity 3.able to comply with study protocol 4. willingly inform consent
排除标准
- •1. unable to stop previous treatment (washout period; systemic treatment 4 weeks, topical treatment 2 weeks). 2. abnormal liver or renal function 3. psychological disorder 4. Pregnant or lactating women 5. allergic to study product.
研究者
相似试验
招募中
2 期
Comparative trial on the effectiveness of topical cannabidiol based on different adhesion times in healthy individuals.Healthy peopleJPRN-jRCT1031230303Yoshizaki Ayumi100
招募中
不适用
The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic DermatitisAtopic DermatitisNCT06022874Phoilex Ltd.30
尚未招募
1 期
Efficacy and Safety of Low-dose Cannabidiol for anxietyAnxietyACTRN12623000803695PharmaCann Pty Ltd80
尚未招募
1 期
Efficacy and Safety of Low-dose Cannabidiol for treatment of sleep disturbancesACTRN12623000802606PharmaCann Pty Ltd80
进行中(未招募)
1 期
Cannabidiol in Treatment of Pain due to Attrition of the Knee JointPainful osteoarthritis of the kneeEUCTR2019-003591-40-ATMedizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie86
